Literature DB >> 29474155

A Multiplexed Mass Spectrometry-Based Assay for Robust Quantification of Phosphosignaling in Response to DNA Damage.

Jeffrey R Whiteaker1, Lei Zhao1, Rick Saul2, Jan A Kaczmarczyk2, Regine M Schoenherr1, Heather D Moore1, Corey Jones-Weinert1, Richard G Ivey1, Chenwei Lin1, Tara Hiltke3, Kerryn W Reding1,4, Gordon Whiteley2, Pei Wang5, Amanda G Paulovich1.   

Abstract

A lack of analytically robust and multiplexed assays has hampered studies of the large, branched phosphosignaling network responsive to DNA damage. To address this need, we developed and fully analytically characterized a 62-plex assay quantifying protein expression and post-translational modification (phosphorylation and ubiquitination) after induction of DNA damage. The linear range was over 3 orders of magnitude, the median inter-assay variability was 10% CV and the vast majority (∼85%) of assays were stable after extended storage. The multiplexed assay was applied in proof-of-principle studies to quantify signaling after exposure to genotoxic stress (ionizing radiation and 4-nitroquinoline 1-oxide) in immortalized cell lines and primary human cells. The effects of genomic variants and pharmacologic kinase inhibition (ATM/ATR) were profiled using the assay. This study demonstrates the utility of a quantitative multiplexed assay for studying cellular signaling dynamics, and the potential application to studies on inter-individual variation in the radiation response.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29474155      PMCID: PMC5939939          DOI: 10.1667/RR14963.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  62 in total

1.  Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Authors:  Eric Kuhn; Jeffrey R Whiteaker; D R Mani; Angela M Jackson; Lei Zhao; Matthew E Pope; Derek Smith; Keith D Rivera; N Leigh Anderson; Steven J Skates; Terry W Pearson; Amanda G Paulovich; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

2.  Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Chenwei Lin; Ping Yan; Pei Wang; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2011-12-27       Impact factor: 5.911

3.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

4.  Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.

Authors:  Andrew N Hoofnagle; Jeffrey R Whiteaker; Steven A Carr; Eric Kuhn; Tao Liu; Sam A Massoni; Stefani N Thomas; R Reid Townsend; Lisa J Zimmerman; Emily Boja; Jing Chen; Daniel L Crimmins; Sherri R Davies; Yuqian Gao; Tara R Hiltke; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Matthew R Meyer; Wei-Jun Qian; Regine M Schoenherr; Mitchell G Scott; Tujin Shi; Gordon R Whiteley; John A Wrobel; Chaochao Wu; Brad L Ackermann; Ruedi Aebersold; David R Barnidge; David M Bunk; Nigel Clarke; Jordan B Fishman; Russ P Grant; Ulrike Kusebauch; Mark M Kushnir; Mark S Lowenthal; Robert L Moritz; Hendrik Neubert; Scott D Patterson; Alan L Rockwood; John Rogers; Ravinder J Singh; Jennifer E Van Eyk; Steven H Wong; Shucha Zhang; Daniel W Chan; Xian Chen; Matthew J Ellis; Daniel C Liebler; Karin D Rodland; Henry Rodriguez; Richard D Smith; Zhen Zhang; Hui Zhang; Amanda G Paulovich
Journal:  Clin Chem       Date:  2016-01       Impact factor: 8.327

5.  Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.

Authors:  Susan E Abbatiello; Birgit Schilling; D R Mani; Lisa J Zimmerman; Steven C Hall; Brendan MacLean; Matthew Albertolle; Simon Allen; Michael Burgess; Michael P Cusack; Mousumi Gosh; Victoria Hedrick; Jason M Held; H Dorota Inerowicz; Angela Jackson; Hasmik Keshishian; Christopher R Kinsinger; John Lyssand; Lee Makowski; Mehdi Mesri; Henry Rodriguez; Paul Rudnick; Pawel Sadowski; Nell Sedransk; Kent Shaddox; Stephen J Skates; Eric Kuhn; Derek Smith; Jeffery R Whiteaker; Corbin Whitwell; Shucha Zhang; Christoph H Borchers; Susan J Fisher; Bradford W Gibson; Daniel C Liebler; Michael J MacCoss; Thomas A Neubert; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2015-02-18       Impact factor: 5.911

6.  Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA.

Authors:  Regine M Schoenherr; Richard G Saul; Jeffrey R Whiteaker; Ping Yan; Gordon R Whiteley; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2014-12-15       Impact factor: 5.911

7.  Radiation sensitivity of Bloom's syndrome lymphocytes during S and G2 phases.

Authors:  A Aurias; J L Antoine; R Assathiany; M Odievre; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1985-03-15

8.  Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Authors:  Steven A Carr; Susan E Abbatiello; Bradley L Ackermann; Christoph Borchers; Bruno Domon; Eric W Deutsch; Russell P Grant; Andrew N Hoofnagle; Ruth Hüttenhain; John M Koomen; Daniel C Liebler; Tao Liu; Brendan MacLean; D R Mani; Elizabeth Mansfield; Hendrik Neubert; Amanda G Paulovich; Lukas Reiter; Olga Vitek; Ruedi Aebersold; Leigh Anderson; Robert Bethem; Josip Blonder; Emily Boja; Julianne Botelho; Michael Boyne; Ralph A Bradshaw; Alma L Burlingame; Daniel Chan; Hasmik Keshishian; Eric Kuhn; Christopher Kinsinger; Jerry S H Lee; Sang-Won Lee; Robert Moritz; Juan Oses-Prieto; Nader Rifai; James Ritchie; Henry Rodriguez; Pothur R Srinivas; R Reid Townsend; Jennifer Van Eyk; Gordon Whiteley; Arun Wiita; Susan Weintraub
Journal:  Mol Cell Proteomics       Date:  2014-01-17       Impact factor: 5.911

9.  Western blots versus selected reaction monitoring assays: time to turn the tables?

Authors:  Ruedi Aebersold; Alma L Burlingame; Ralph A Bradshaw
Journal:  Mol Cell Proteomics       Date:  2013-06-10       Impact factor: 5.911

10.  Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.

Authors:  Jason M Beckta; Seth M Dever; Nisha Gnawali; Ashraf Khalil; Amrita Sule; Sarah E Golding; Elizabeth Rosenberg; Aarthi Narayanan; Kylene Kehn-Hall; Bo Xu; Lawrence F Povirk; Kristoffer Valerie
Journal:  Oncotarget       Date:  2015-09-29
View more
  11 in total

Review 1.  Protein identification strategies in MALDI imaging mass spectrometry: a brief review.

Authors:  Daniel J Ryan; Jeffrey M Spraggins; Richard M Caprioli
Journal:  Curr Opin Chem Biol       Date:  2018-11-23       Impact factor: 8.822

2.  Time-Dependent Measurement of Nrf2-Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation Injury.

Authors:  Kate Liu; Elizabeth Singer; Whitaker Cohn; Ewa D Micewicz; William H McBride; Julian P Whitelegge; Joseph A Loo
Journal:  Proteomics Clin Appl       Date:  2019-09-04       Impact factor: 3.494

Review 3.  Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells.

Authors:  Jacqueline S Gerritsen; Forest M White
Journal:  Expert Rev Proteomics       Date:  2021-09-16       Impact factor: 4.250

Review 4.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

5.  Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Richard G Ivey; Marilyn Sanchez-Bonilla; Heather D Moore; Regine M Schoenherr; Ping Yan; Chenwei Lin; Akiko Shimamura; Amanda G Paulovich
Journal:  DNA Repair (Amst)       Date:  2018-03-21

6.  Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.

Authors:  Jeffrey R Whiteaker; Rachel A Lundeen; Lei Zhao; Regine M Schoenherr; Aura Burian; Dongqing Huang; Ulianna Voytovich; Tao Wang; Jacob J Kennedy; Richard G Ivey; Chenwei Lin; Oscar D Murillo; Travis D Lorentzen; Mathangi Thiagarajan; Simona Colantonio; Tessa W Caceres; Rhonda R Roberts; Joseph G Knotts; Joshua J Reading; Jan A Kaczmarczyk; Christopher W Richardson; Sandra S Garcia-Buntley; William Bocik; Stephen M Hewitt; Karen E Murray; Nhan Do; Mary Brophy; Stephen W Wilz; Hongbo Yu; Samuel Ajjarapu; Emily Boja; Tara Hiltke; Henry Rodriguez; Amanda G Paulovich
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 8.786

7.  Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.

Authors:  Qi Liu; Luis Palomero; Jade Moore; Ines Guix; Roderic Espín; Alvaro Aytés; Jian-Hua Mao; Amanda G Paulovich; Jeffrey R Whiteaker; Richard G Ivey; George Iliakis; Daxian Luo; Anthony J Chalmers; John Murnane; Miquel Angel Pujana; Mary Helen Barcellos-Hoff
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

8.  pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.

Authors:  Gemma N Jones; Claire Rooney; Nicola Griffin; Martine Roudier; Lucy A Young; Antonio Garcia-Trinidad; Gareth D Hughes; Jeffrey R Whiteaker; Zena Wilson; Rajesh Odedra; Lei Zhao; Richard G Ivey; William J Howat; Elizabeth A Harrington; J Carl Barrett; Antonio Ramos-Montoya; Alan Lau; Amanda G Paulovich; Elaine B Cadogan; Andrew J Pierce
Journal:  Br J Cancer       Date:  2018-11-02       Impact factor: 7.640

9.  Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.

Authors:  Jeffrey R Whiteaker; Tao Wang; Lei Zhao; Regine M Schoenherr; Jacob J Kennedy; Ulianna Voytovich; Richard G Ivey; Dongqing Huang; Chenwei Lin; Simona Colantonio; Tessa W Caceres; Rhonda R Roberts; Joseph G Knotts; Jan A Kaczmarczyk; Josip Blonder; Joshua J Reading; Christopher W Richardson; Stephen M Hewitt; Sandra S Garcia-Buntley; William Bocik; Tara Hiltke; Henry Rodriguez; Elizabeth A Harrington; J Carl Barrett; Benedetta Lombardi; Paola Marco-Casanova; Andrew J Pierce; Amanda G Paulovich
Journal:  Cancers (Basel)       Date:  2021-07-30       Impact factor: 6.575

10.  A highly multiplexed quantitative phosphosite assay for biology and preclinical studies.

Authors:  Hasmik Keshishian; E Robert McDonald; Filip Mundt; Randy Melanson; Karsten Krug; Dale A Porter; Luke Wallace; Dominique Forestier; Bokang Rabasha; Sara E Marlow; Judit Jane-Valbuena; Ellen Todres; Harrison Specht; Margaret Lea Robinson; Pierre M Jean Beltran; Ozgun Babur; Meagan E Olive; Javad Golji; Eric Kuhn; Michael Burgess; Melanie A MacMullan; Tomas Rejtar; Karen Wang; D R Mani; Shankha Satpathy; Michael A Gillette; William R Sellers; Steven A Carr
Journal:  Mol Syst Biol       Date:  2021-09       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.